Japara Healthcare Limited re-affirmed earnings guidance for fiscal year 2015. The company expects EBITDA of about $50.3 million, including Whelan Care. Excluding Whelan, the company reaffirmed its prospectus pro forma EBITDA guidance of $48.9 million.